Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.2M Buy
359,011
+90,581
+34% +$10.5M 0.91% 27
2025
Q4
$28.5M Sell
268,430
-3
-0% -$282 1.06% 28
2025
Q3
$22.7M Buy
268,433
+1
+0% +$82 0.86% 31
2025
Q2
$21.5M Buy
268,432
+267,437
+26,878% +$21.3M 0.88% 30
2025
Q1
$89.3K Buy
+995
New +$92.9K 0.47% 33

Other funds holding MRK

Saudi Central Bank's MRK Position: Q1 2026 in Review

Saudi Central Bank increased its Merck (MRK) stake by 34% in Q1 2026, buying an estimated $10.5M and bringing the position to 359,011 shares worth $43.2M. The position accounts for 0.91% of the portfolio, ranked #27.

Saudi Central Bank first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Saudi Central Bank held 359,011 shares of Merck worth $43.2M as of Q1 2026.
  • Saudi Central Bank bought 90,581 Merck shares in Q1 2026, an estimated $10.5M.
  • Merck made up 0.91% of Saudi Central Bank's portfolio in Q1 2026, its #27 holding.
  • Saudi Central Bank first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Saudi Central Bank's 13F filing for Q1 2026, filed 15 May 2026.